Resistance of Group A β-hemolytic streptococcus
10.3760/cma.j.issn.2095-428X.2016.04.002
- VernacularTitle:A族β溶血性链球菌耐药
- Author:
Yunmei LIANG
;
Miao LI
;
Fang GUO
;
Jin ZHANG
;
Siqi REN
- Publication Type:Journal Article
- Keywords:
Group A β-hemolytic streptococcus;
Macrolide antibiotics;
Resistance
- From:
Chinese Journal of Applied Clinical Pediatrics
2016;(4):244-247
- CountryChina
- Language:Chinese
-
Abstract:
Group A β-hemolytic streptococcus (GAS),namely Streptococcus pyogenes,is one of the most im-portant human pathogen.GAS can cause skin and mucous membrane superficial infectious diseases,life -threatening invasive disease,toxin -mediated diseases and immune -related diseases.Antibiotic is an effective mean to control GAS infection.The β-lactam antibiotics remain the first -choice treatment for GAS infection and the macrolides are often recommended as a replacement therapy for β-lactam antibiotics allergic patients or a means to blocking GAS exotoxin product.But with the widespread use of macrolides autibiotics,macrolide -resistant GAS spread in the world. This paper will elaborate the situation of macrolide -resistant clones.
